1887

Abstract

Screening women for lower genital tract infection with is important in the prevention of pelvic inflammatory disease, ectopic pregnancy and infertility. This systematic review aims to state clearly which of the available diagnostic tests for the detection of would be most effective in terms of clinical effectiveness. The review included all studies published from 1990 onward that evaluated diagnostic tests in asymptomatic, young, sexually active populations. Medline and Embase were searched electronically and key journals were hand-searched. Further studies were identified through the Internet and contact with experts in the field. All studies were reviewed by two reviewers and were scored by Irwig's assessment criteria. Additional quality assessment criteria included a documented sexual history and recording of previous chlamydial infection. The reviews were subjected to meta-analysis and meta-regression. The 30 studies that were included examined three types of DNA-based test – ligase chain reaction (LCR), PCR and gene probe – as well as enzyme immuno-assay (EIA). The results showed that while specificities were high, sensitivities varied widely across the tests and were also dependent on the specimen tested. Pooled sensitivities for LCR, PCR, gene probe and EIA on urine were 96.5%, 85.6%, 92% and 38%, respectively, while on cervical swabs the corresponding sensitivities of PCR, gene probe and EIA were 88.6%, 84% and 65%. Meta-analysis demonstrated that DNA amplification techniques performed best for both urine and swabs in low prevalence populations. We conclude that nucleic acid amplification tests used on non-invasive samples such as urine are more effective at detecting asymptomatic chlamydial infection than conventional tests, but there are few data to relate a positive result with clinical outcome.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/0022-1317-51-12-1021
2002-12-01
2024-04-16
Loading full text...

Full text loading...

/deliver/fulltext/jmm/51/12/1021.html?itemId=/content/journal/jmm/10.1099/0022-1317-51-12-1021&mimeType=html&fmt=ahah

References

  1. Gaydos CA, Howell MR, Pare B. et al. Chlamydia trachomatis infections in female military recruits. N Engl J Med 1998; 339:739–744 [CrossRef]
    [Google Scholar]
  2. Svensson LO, Mares I, Olsson SE, Nordstrom ML. Screening for Chlamydia trachomatis infection in women and aspects of the laboratory diagnostics. Acta Obstet Gynecol Scand 1991; 70:587–590 [CrossRef]
    [Google Scholar]
  3. Stamm WE. Chlamydia trachomatis infections: progress and problems. J Infect Dis 1999; 179 Suppl 2:S380–S383 [CrossRef]
    [Google Scholar]
  4. Department of Health Why Mothers Die. Report on confidential enquiries into maternal deaths in the United Kingdom 1994–1996 London: Stationery Office; 1998
    [Google Scholar]
  5. Stray-Pedersen B. Is screening for genital infections in pregnancy necessary? Acta Obstet Gynecol Scand ; 1997; 76 Suppl 164116–120
  6. Stary A. Chlamydia screening: which sample for which technique?. Genitourin Med 1997; 73:99–102
    [Google Scholar]
  7. Jang D, Sellors JW, Mahony JB, Pickard L, Chernesky MA. Effects of broadening the gold standard on the performance of a chemiluminometric immunoassay to detect Chlamydia trachomatis antigens in centrifuged first void urine and urethral swab samples from men. Sex Transm Dis 1992; 19:315–319 [CrossRef]
    [Google Scholar]
  8. Taylor-Robinson D. Tests for infection with Chlamydia trachomatis . Int J STD AIDS 1996; 7:19–26
    [Google Scholar]
  9. Rota S, Yildiz A, Kustimur S, Akbas E, Gunay A, Guner H. Sample adequacy in detecting Chlamydia trachomatis . Int J Gynecol Obstet 1995; 51:225–228 [CrossRef]
    [Google Scholar]
  10. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997; 10:160–184
    [Google Scholar]
  11. Duncan B, Hart G. Sexuality and health: the hidden costs of screening for Chlamydia trachomatis . BMJ 1999; 318:931–933 [CrossRef]
    [Google Scholar]
  12. Clad A, Prillwitz J, Hintz KC. et al. Discordant prevalence of Chlamydia trachomatis in asymptomatic couples screened using urine ligase chain reaction. Eur J Clin Microbiol Infect Dis 2001; 20:324–328 [CrossRef]
    [Google Scholar]
  13. Earle C, Hébert PC. A reader's guide to the evaluation of screening studies. Postgrad Med J 1996; 72:77–83 [CrossRef]
    [Google Scholar]
  14. Irwig L, Totseton ANA, Gastonis C. et al. Guidelines for meta analysis evaluating diagnostic tests. Ann Intern Med 1994; 120:667–676 [CrossRef]
    [Google Scholar]
  15. Grun L, Tassano-Smith J. Comparison of two methods of screening for genital chlamydial infection in women attending in general paractice: cross sectional survey. BMJ 1997; 315:226–230 [CrossRef]
    [Google Scholar]
  16. Mårdh PA, Ripa T, Svensson L, Westrom L. Chlamydia trachomatis infection in patients with acute salpingitis. N Engl J Med 1977; 296:1377–1379 [CrossRef]
    [Google Scholar]
  17. Stary A, Tomazic-Allen S, Choueiri B, Burczak J, Steyrer K, Lee H. Comparison of DNA amplification methods for the detection of Chlamydia trachomatis in first-void urine from asymptomatic military recruits. Sex Transm Dis 1996; 23:97–102 [CrossRef]
    [Google Scholar]
  18. Adjei O, Lal V. Non-invasive detection of Chlamydia trachomatis genital infections in asymptomatic males and females by enzyme immunoassay (Chlamydiazyme). J Trop Med Hyg 1994; 97:51–54
    [Google Scholar]
  19. Bass CA, Jungkind DL, Silverman NS, Bondi JM. Clinical evaluation of a new polymerase chain reaction assay for detection of Chlamydia trachomatis in endocervical specimens. J Clin Microbiol 1993; 31:2648–2653
    [Google Scholar]
  20. Bassiri M, Mårdh P-A, Domeika M. Multiplex AMPLICOR PCR screening for Chlamydia trachomatis and Neisseria gonorrhoeae in women attenting non-sexually transmitted disease clinics.The European Chlamydia Epidemiology Group. J Clin Microbiol 1997; 35:2556–2560
    [Google Scholar]
  21. Bassiri M, Hu HY, Domeika MA. et al. Detection of Chlamydia trachomatis in urine specimens from women by ligase chain reaction. J Clin Microbiol 1995; 33:898–900
    [Google Scholar]
  22. Biro FM, Reising SF, Doughman JA, Kollar LM, Rosenthal SL. A comparison of diagnostic methods in adolescent girls with and without symptoms of Chlamydia urogenital infection. Pediatrics 1994; 93:476–480
    [Google Scholar]
  23. Bowden FJ. Reappraising the value of urine leukocyte esterase testing in the age of nucleic acid amplification. Sex Transm Dis 1998; 25:322–326 [CrossRef]
    [Google Scholar]
  24. Braverman PK, Biro FM, Brunner RL, Gilchrist MJ, Rauh JL. Screening asymptomatic adolescent males for chlamydia. J Adolesc Health Care 1990; 11:141–144 [CrossRef]
    [Google Scholar]
  25. Brokenshire MK, Say PJ, van Vonno AH, Wong C. Evaluation of the microparticle enzyme immunoassay Abbott IMx Select Chlamydia and the importance of urethral site sampling to detect Chlamydia trachomatis in women. Genitourin Med 1997; 73:498–502
    [Google Scholar]
  26. Catry MA, Borrego MJ, Cardoso J, Azevedo J, Santo I. Comparison of the Amplicor Chlamydia trachomatis test and cell culture for the detection of urogenital chlamydial infections. Genitourin Med 1995; 71:247–250
    [Google Scholar]
  27. Chernesky MA, Jang D, Lee H. et al. Diagnosis of Chlamydia trachomatis infections in men and women by testing first-void urine by ligase chain reaction. J Clin Microbiol 1994; 32:2682–2685
    [Google Scholar]
  28. Chout R, Vaton S, Quist D, Bucher R, Leguyader-Desprees P, Sayada C. Improvement of cervical Chlamydia detection in asymptomatic family planning attendees by using Amplicor Chlamydia trachomatis assay. Cell Mol Biol 1995; 41:731–736
    [Google Scholar]
  29. Cook RL, St George K, Lassak M, Tran N, Anhalt JP, Rinaldo CR. Screening for Chlamydia trachomatis infection in college women with a polymerase chain reaction assay. Clin Infect Dis 1999; 28:1002–1007 [CrossRef]
    [Google Scholar]
  30. de Barbeyrac B, Pellet I, Dutilh B, Bebear C, Dumon B, Geniaux M. Evaluation of the Amplicor Chlamydia trachomatis test versus culture in genital samples in various prevalence populations. Genitourin Med 1994; 70:162–166
    [Google Scholar]
  31. Ferrero DV, Meyers HN, Schultz DE, Willis SA. Performance of the Gen-Probe AMPLIFIED Chlamydia trachomatis Assay in detecting Chlamydia trachomatis in endocervical and urine specimens from women and urethral and urine specimens from men attending sexually transmitted disease and family planning clinics. J Clin Microbiol 1998; 36:3230–3233
    [Google Scholar]
  32. Gaydos CA, Howell MR, Quinn TC, Gaydos JC, McKee KT. Use of ligase chain reaction with urine versus cervical culture for detection of Chlamydia trachomatis in an asymptomatic military population of pregnant and nonpregnant females attending Papanicolaou smear clinics. J Clin Microbiol 1998; 36:1300–1304
    [Google Scholar]
  33. Kay ID, Palladino S, Alexander R, Leahy BJ, Pearman JW. Evaluation of a commercial polymerase chain reaction assay for the detection of Chlamydia trachomatis . Diagn Microbiol Infect Dis 1997; 28:75–79 [CrossRef]
    [Google Scholar]
  34. Loeffelholz MJ, Lewinski CA, Silver SR et al. Detection of Chlamydia trachomatis in endocervical specimens by polymerase chain reaction. J Clin Microbiol 1992; 30:2847–2851
    [Google Scholar]
  35. McNagny SE, Parker RM, Zenilman JM, Lewis JS. Urinary leukocyte esterase test: a screening method for the detection of asymptomatic chlamydial and gonococcal infections in men. J Infect Dis 1992; 165:573–576 [CrossRef]
    [Google Scholar]
  36. Marrazzo JM, White CL, Krekeler B. et al. Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med 1997; 127:796–803 [CrossRef]
    [Google Scholar]
  37. Pasternack R, Vuorinen P, Kuukankorpi A, Pitkäjärvi T, Miettinen A. Detection of Chlamydia trachomatis infections in women by Amplicor PCR: comparison of diagnostic performance with urine and cervical specimens. J Clin Microbiol 1996; 34:995–998
    [Google Scholar]
  38. Paukku M, Puolakkainen M, Apter D, Hirvonen S, Paavonen J. First-void urine testing for Chlamydia trachomatis by polymerase chain reaction in asymptomatic women. Sex Transm Dis 1997; 24:343–346 [CrossRef]
    [Google Scholar]
  39. Rahm VA, Gnarpe H, Odlind V. Evaluation of a direct fluorescence assay as a screening method in asymptomatic young women. Sex Transm Dis 1992; 19:84–87 [CrossRef]
    [Google Scholar]
  40. Schachter J, Moncada J, Whidden R. et al. Noninvasive tests for diagnosis of Chlamydia trachomatis infection: application of ligase chain reaction to first-catch urine specimens of women. J Infect Dis 1995; 172:1411–1414 [CrossRef]
    [Google Scholar]
  41. Schubiner HH, Lebar W, Jemal C, Hershman B. Comparison of three new nonculture tests in the diagnosis of Chlamydia genital infections. J Adolesc Health Care 1990; 11:505–509 [CrossRef]
    [Google Scholar]
  42. Shafer M-A, Schachter J, Moncada J. et al. Evaluation of urine-based screening strategies to detect Chlamydia trachomatis among sexually active asymptomatic young males. JAMA 1993; 270:2065–2070 [CrossRef]
    [Google Scholar]
  43. Skulnick M, Chua R, Simor AE. et al. Use of the polymerase chain reaction for the detection of Chlamydia trachomatis from endocervical and urine specimens in an asymptomatic low-prevalence population of women. Diagn Microbiol Infect Dis 1994; 20:195–201 [CrossRef]
    [Google Scholar]
  44. Thejls H, Gnarpe J, Gnarpe H. et al. Expanded gold standard in the diagnosis of Chlamydia trachomatis in a low prevalence population: diagnostic efficacy of tissue culture, direct immunofluorescence, enzyme immunoassay, PCR and serology. Genitourin Med 1994; 70:300–303
    [Google Scholar]
  45. Toye B, Peeling RW, Jessamine P, Claman P, Gemmill I. Diagnosis of Chlamydia trachomatis infections in asymptomatic men and women by PCR assay. J Clin Microbiol 1996; 34:1396–1400
    [Google Scholar]
  46. Vincelette J, Schirm J, Bogard M. et al. Multicenter evaluation of the fully automated COBAS AMPLICOR PCR test for detection of Chlamydia trachomatis in urogenital specimens. J Clin Microbiol 1999; 37:74–80
    [Google Scholar]
  47. Ånestad G, Berdal BP, Scheel O. et al. Screening urine samples by leukocyte esterase test and ligase chain reaction for chlamydial infections among asymptomatic men. J Clin Microbiol 1995; 33:2483–2484
    [Google Scholar]
  48. Moncada J, Schachter J, Bolan G. et al. Evaluation of Syva's enzyme immunoassay for the detection of Chlamydia trachomatis in urogenital specimens. Diagn Microbiol Infect Dis 1992; 15:663–668 [CrossRef]
    [Google Scholar]
  49. Altaie SS, Meier FA, Centor RM. et al. Evaluation of two ELISA's for detecting Chlamydia trachomatis from endocervical swabs. Diagn Microbiol Infect Dis 1992; 15:579–586 [CrossRef]
    [Google Scholar]
  50. Andersen B, Østergaard L, Møller JK, Olesen F. Home sampling versus conventional contact tracing for detecting Chlamydia trachomatis infection in male partners of infected women: randomised study. BMJ 1998; 316:350–351 [CrossRef]
    [Google Scholar]
  51. Beck-Sague CM, Farshy CE, Jackson TK. et al. Detection of Chlamydia trachomatis cervical infection by urine tests among adolescents clinics. J Adolesc Health 1998; 22:197–204 [CrossRef]
    [Google Scholar]
  52. Blanding J, Hirsch L, Stranton N. et al. Comparison of the Clearview Chlamydia, the PACE 2 assay, and culture for detection of Chlamydia trachomatis from cervical specimens in a low-prevalence population. J Clin Microbiol 1993; 31:1622–1625
    [Google Scholar]
  53. Bygdeman SM, Johansson M, Jonasson J. et al. Magic Lite chlamydia immunoassay in urogenital samples and urine versus chlamydial culture. Int J STD AIDS 1994; 5:207–211
    [Google Scholar]
  54. Carroll KC, Aldeen WE, Morrison M, Anderson R, Lee D, Mottice S. Evaluation of the Abbott LCx ligase chain reaction assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and genital swab specimens from a sexually transmitted disease clinic population. J Clin Microbiol 1998; 36:1630–1633
    [Google Scholar]
  55. Chan EL, Brandt K, Stoneham H, Horsman G. Comparison of the Sanofi Diagnostics Pasteur Chlamydia Microplate EIA shortened assay with the original standard assay and cell culture. J Med Microbiol 1997; 46:711–713 [CrossRef]
    [Google Scholar]
  56. Crotchfelt KA, Welsh LE, DeBonville D, Rosenstraus M, Quinn TC. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in genitourinary specimens from men and women by a coamplification PCR assay. J Clin Microbiol 1997; 35:1536–1540
    [Google Scholar]
  57. Chun Y, Yin ZD. Glycogen assay for diagnosis of female genital Chlamydia trachomatis infection. J Clin Microbiol 1996; 36:1081–1082
    [Google Scholar]
  58. Davis JD, Riley PK, Peters CW, Rand KH. A comparison of ligase chain reaction to polymerase chain reaction in the detection of Chlamydia trachomatis endocervical infections. Infect Dis Obstet Gynecol 1998; 6:57–60 [CrossRef]
    [Google Scholar]
  59. de Barbeyrac B, Rodriguez P, Dutilh B, Le Roux P, Bebear C. Detection of Chlamydia trachomatis by ligase chain reaction compared with polymerase chain reaction and cell culture in urogenital specimens. Genitourin Med 1995; 71:382–386
    [Google Scholar]
  60. Dean D, Ferrero D, McCarthy M. Comparison of performance and cost-effectiveness of direct fluorescent-antibody, ligase chain reaction, and PCR assays for verification of chlamydial enzyme immunoassay results for populations with a low to moderate prevalence of Chlamydia trachomatis infection. J Clin Microbiol 1998; 36:94–99
    [Google Scholar]
  61. Dille BJ, Butzen CC, Birkenmeyer LG. Amplification of Chlamydia trachomatis DNA by ligase chain reaction. J Clin Microbiol 1993; 31:729–731
    [Google Scholar]
  62. Doing KM, Curtis K, Long JW, Volock ML. Prospective comparison of the Gen-probe PACE 2 assay and the Abbott ligase chain reaction for the direct detection of Chlamydia trachomatis in a low prevalence population. J Med Microbiol 1999; 48:507–510 [CrossRef]
    [Google Scholar]
  63. Ehret JM, Leszcynski JC, Douglas JM. et al. Evaluation of chlamydiazyme enzyme immunoassay for detection of Chlamydia trachomatis in urine specimens from men. J Clin Microbiol 1993; 31:2702–2705
    [Google Scholar]
  64. Gaydos CA, Ngeow YF, Lee HH. et al. Urine as a diagnostic specimen for the detection of Chlamydia trachomatis in Malaysia by ligase chain reaction. Sex Transm Dis 1996; 23:402–406 [CrossRef]
    [Google Scholar]
  65. Hook EW, Smith K, Mullen C. et al. Diagnosis of genitourinary Chlamydia trachomatis infections by using the ligase chain reaction on patient-obtained vaginal swabs. J Clin Microbiol 1997; 35:2133–2135
    [Google Scholar]
  66. Jaschek G, Gaydos CA, Welsh LE, Quinn TC. Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay. J Clin Microbiol 1993; 31:1209–1212
    [Google Scholar]
  67. Kellogg JA, Vanderhoff BT, Seiple JW, Hick ME. Comparison of first-voided urine specimens with endocervical swab specimens for enzyme-linked immunosorbent assay detection of Chlamydia trachomatis in women. Arch Fam Med 1994; 3:672–675 [CrossRef]
    [Google Scholar]
  68. Lee HH, Chernesky MA, Schachter J. et al. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet 1995; 345:213–216 [CrossRef]
    [Google Scholar]
  69. Leonardi GP, Seitz M, Edstrom R, Cruz J, Costello P, Szabo K. Evaluation of three immunoassays for detection of Chlamydia trachomatis in urine specimens from asymptomatic males. J Clin Microbiol 1992; 30:2793–2796
    [Google Scholar]
  70. Miyashita N, Iijima Y, Matsumoto A. Evaluation of the sensitivity and specificity of polymerase chain reaction test kit, AMPLICOR Chlamydia trachomatis . Microbiol Immunol 1994; 38:81–85 [CrossRef]
    [Google Scholar]
  71. Newhall WJ, Johnson RE, DeLisle S. et al. Head-to-head evaluation of five chlamydia tests relative to a quality-assured culture standard. J Clin Microbiol 1999; 37:681–685
    [Google Scholar]
  72. Østergaard L, Andersen B, Olesen F, Møller JK. Efficacy of home sampling for screening of Chlamydia trachomatis : randomised study. BMJ 1998; 317:26–27 [CrossRef]
    [Google Scholar]
  73. Pasternack R, Vuorinen P, Miettinen A. Evaluation of the Gen-Probe Chlamydia trachomatis transcription-mediated amplification assay with urine specimens from women. J Clin Microbiol 1997; 35:676–678
    [Google Scholar]
  74. Pate MS, Dixon PB, Hardy K, Crosby M, Hook EW. Evaluation of the Biostar Chlamydia OIA assay with specimens from women attending a sexually transmitted disease clinic. J Clin Microbiol 1998; 36:2183–2186
    [Google Scholar]
  75. Puolakkainen M, Hiltunen-Back E, Reunala T. et al. Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection. J Clin Microbiol 1998; 36:1489–1493
    [Google Scholar]
  76. Quinn TC, Welsh L, Lentz A. et al. Diagnosis by AMPLICOR PCR of Chlamydia trachomatis infection in urine samples from women and men attending sexually transmitted disease clinics. J Clin Microbiol 1996; 34:1401–1406
    [Google Scholar]
  77. Ridgway GL, Mumtaz G, Robinson AJ. et al. Comparison of the ligase chain reaction with cell culture for the diagnosis of Chlamydia trachomatis infection in women. J Clin Pathol 1996; 49:116–119 [CrossRef]
    [Google Scholar]
  78. Roymans RTJM, Onland G, Postma BH. One-day detection of PCR amplified Chlamydia trachomatis DNA in clinical samples: ELISA versus Southern blot hybridisation. J Clin Pathol 1996; 49:581–583 [CrossRef]
    [Google Scholar]
  79. Rumpianesi F, La Placa M, D'Antuono A, Negosanti M, Pavan G. Assessment of the "Amplicor" PCR test in the diagnosis of Chlamydia trachomatis infection. New Microbiol 1993; 16:293–295
    [Google Scholar]
  80. Sanders JW, Hook EW, Welsh LE, Shepherd ME, Quinn TC. Evaluation of an enzyme immunoassay for detection of Chlamydia trachomatis in urine of asymptomatic men. J Clin Microbiol 1994; 32:24–27
    [Google Scholar]
  81. Schachter J, Stamm WE, Quinn TC, Andrews WW, Burczak JD, Lee HH. Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix. J Clin Microbiol 1994; 32:2540–2543
    [Google Scholar]
  82. Sellors JW, Mahony JB, Jang D. et al. Comparison of cervical, urethral, and urine specimens for the detection of Chlamydia trachomatis in women. J Infect Dis 1991; 164:205–208 [CrossRef]
    [Google Scholar]
  83. Smith BL, Cummings MC, Benes S, McCormack WM. Evaluation of vaginal tampons for collection of specimens for detection of chlamydial infection. Sex Transm Dis 1996; 23:127–130 [CrossRef]
    [Google Scholar]
  84. Stary A, Najim B, Lee HH. Vulval swabs as alternative specimens for ligase chain reaction detection of genital chlamydial infection in women. J Clin Microbiol 1997; 35:836–838
    [Google Scholar]
  85. Stary A, Schuh E, Kerschbaumer M, Götz B, Lee H. Performance of transcription-mediated amplification and ligase chain reaction assays for detection of chlamydial infection in urogenital samples obtained by invasive and noninvasive methods. J Clin Microbiol 1998; 36:2666–2670
    [Google Scholar]
  86. Tabrizi SN, Paterson B, Fairley CK, Bowden FJ, Garland SM. A self-administered technique for the detection of sexually transmitted diseases in remote communities. J Infect Dis 1997; 176:289–292 [CrossRef]
    [Google Scholar]
  87. Tong CYW, Donnelly C, Hood N. Lowering the cut off value of an automated chlamydia enzyme immunoassay and confirmation by PCR and direct immunofluorescent antibody test. J Clin Pathol 1997; 50:681–685 [CrossRef]
    [Google Scholar]
  88. Witkin SS, Inglis SR, Polaneczky M. Detection of Chlamydia trachomatis and Trichomonas vaginalis by polymerase chain reaction in introital specimens from pregnant women. Am J Obstet Gynecol 1996; 175:165–167 [CrossRef]
    [Google Scholar]
  89. Wylie JL, Moses S, Babcock R, Jolly A, Giercke S, Hammond G. Comparative evaluation of chlamydiazyme, PACE 2, and AMP-CT assays for detection of Chlamydia trachomatis in endocervical specimens. J Clin Microbiol 1998; 36:3488–3491
    [Google Scholar]
  90. Woods GL, Bryan JA. Detection of Chlamydia trachomatis by direct fluorescent antibody staining.Results of the College of American Pathologists Proficiency Testing Program, 1986–1992. Arch Pathol Lab Med 1994; 118:483–488
    [Google Scholar]
  91. Hay PE, Thomas BJ, Horner PJ, MacLeod E, Renton AM, Taylor-Robinson D. Chlamydia trachomatis in women: the more you look, the more you find. Genitourin Med 1994; 70:97–100
    [Google Scholar]
  92. Kacena KA, Quinn SB, Howell MR, Madico GE, Quinn TC, Gaydos CA. Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women. J Clin Microbiol 1998; 36:481–485
    [Google Scholar]
  93. Mahony J, Chong S, Jang D. et al. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity. J Clin Microbiol 1998; 36:3122–3126
    [Google Scholar]
  94. Morré SA, van Valkengoed IGM, de Jong A. et al. Mailed, home-obtained urine specimens: a reliable screening approach for detecting asymptomatic Chlamydia trachomatis infections. J Clin Microbiol 1999; 37:976–980
    [Google Scholar]
  95. Schachter J, Shafer M-A, Young M, Ott M. Routine pelvic examinations in asymptomatic young women. N Engl J Med 1996; 335:1847–1848 [CrossRef]
    [Google Scholar]
  96. Joyner JL, Douglas JM, Foster M, Judson FN. Persistence of Chlamydia trachomatis infection detected by polymerase chain reaction in untreated patients. Sex Transm Dis 2002; 29:196–200 [CrossRef]
    [Google Scholar]
  97. Taylor-Robinson D. Chlamydia trachomatis and sexually transmitted disease. BMJ 1994; 308:150–151 [CrossRef]
    [Google Scholar]
  98. Egger M, Low N, Smith GD, Lindblom B, Herrmann B. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ 1998; 316:1776–1780 [CrossRef]
    [Google Scholar]
  99. Moore RA. The 4th Bandolier conference: Chlamydia. Screening – using evidence on Chlamydia. http://www.jr2.ox. ac.uk/bandolier/bandopubs/bandocon4/chlamyd
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/0022-1317-51-12-1021
Loading
/content/journal/jmm/10.1099/0022-1317-51-12-1021
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error